Skip to main content
Clinical Trials/NCT03444532
NCT03444532
Completed
Not Applicable

Feasibility Study of a Randomized Controlled Trial Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia

Danish Cancer Society1 site in 1 country12 target enrollmentMarch 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer of Prostate
Sponsor
Danish Cancer Society
Enrollment
12
Locations
1
Primary Endpoint
Sleep
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study of a randomized controlled trial aims to evaluate the feasibility of a 12-week sleep program and the randomized controlled trial research procedure. In total 20 participants will be recruited and randomized to the intervention or control group.

Detailed Description

This feasibility study of a randomized controlled trial, aims to evaluate the feasibility of a 12-week sleep program consisting on aerobic exercise and cognitive-behavioral therapy. In this study the investigators wish to evaluate the program as well as the randomized controlled trial research procedure. In total 20 participants will be recruited and randomized to either the intervention group (n=10) or control group (n=10).The intervention group will participate in two exercise sessions each week and four sessions based on cognitive-behavioral therapy for insomnia.

Registry
clinicaltrials.gov
Start Date
March 2, 2018
End Date
May 31, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christoffer Johansen

Professor

Danish Cancer Society

Eligibility Criteria

Inclusion Criteria

  • Prostate cancer
  • Receiving treatment with androgen deprivation therapy or in combination with chemotherapy
  • Over 18-yers old
  • Understand oral and written Danish
  • Written informed consent

Exclusion Criteria

  • Medical assessment that does not allow aerobic exercise
  • Severe cognitive problems
  • Night work during the interventions period
  • Exercise training more than three times a week

Outcomes

Primary Outcomes

Sleep

Time Frame: Change from baseline sleep at 12 weeks

Measured by actigraphy, to investigate change in sleep from baseline to 12 weeks and the difference in change between intervention - and the control group

Secondary Outcomes

  • Quality of life(Baseline, 12 weeks, 6 month)
  • Stress(Baseline, 12 weeks, 6 month)
  • Physical activity(Baseline, 12 weeks)
  • Insomnia(Baseline, 12 weeks, 6 month)
  • Fatigue(Baseline, 12 weeks, 6 month)
  • Depression(Baseline, 12 weeks, 6 month)
  • Cardiorespiratory fitness(Baseline, 12-weeks)
  • Anxiety(Baseline, 12 weeks, 6 month)
  • Sleep quality(Baseline, 12 weeks, 6 month)
  • Sleep pattern(Baseline, 12 weeks, 6 month)

Study Sites (1)

Loading locations...

Similar Trials